Merck's Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study results

📆 4/26/2019 3:42 PM
📰 MarketWatch

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Merck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of the drugmaker were down 0.05% in premarket trade. An earlier Phase 3 study looking at Keytruda as a second-line treatment for gastric cancer also failed to show a survival benefit, though the Food and Drug Administration did approve the drug in 2017 as a third-line treatment for patients with advanced gastric cancer. Keytruda is currently used for many other cancer indications, including treating certain subsets of patients with melanoma, lung cancer, Hodgkin lymphoma and cervical cancer, among many others. Shares of the pharmaceutical giant have fallen 0.1% in the year to date, while the S&P 500 has gained 16.7%.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck's Keytruda wins FDA approval as combination therapy for kidney cancerThe U.S. Food and Drug Administration has approved Merck & Co Inc's cancer ...
Source: Reuters - 🏆 2. / 97 Read more »

Possible 2020 contender Michael Bennet gets clean bill of health after cancer treatmentColorado Sen. Michael Bennet, who is contemplating jumping in the crowded 2020 Democratic presidential race, has been given a clean bill of health after undergoing surgery to remove cancer, his office said in a statement. LACaldwellDC Congrats that’s great news to hear LACaldwellDC I think an inanimate object would be a better president than Trump, but this is still good to hear. LACaldwellDC Who
Source: NBCNews - 🏆 10. / 86 Read more »

Experimental treatment for peanut allergy increases anaphylaxis risk, study findsAn experimental treatment for peanut allergy may actually multiply someone's risk for serious allergic reactions -- much like the ones it aims to prevent, according to a new analysis. Biden sucks nuts. So strange that tasty treat for most people is deadly as hell to many people strange to think about. Liberals should just stop having children.
Source: CNN - 🏆 4. / 95 Read more »

Possible 2020 contender Michael Bennet gets clean bill of health after cancer treatmentColorado Sen. Michael Bennet, who is contemplating jumping in the crowded 2020 Democratic presidential race, has been given a clean bill of health after undergoing surgery to remove cancer, his office said in a statement. THAT IS WONDERFUL NEWS! Blessings to him and his family!!!
Source: MSNBC - 🏆 469. / 51 Read more »

Medicare proposes higher payments for innovative cancer treatmentIf approved, the increased reimbursements for CAR T-cell therapy and “breakthrough” devices would go into effect on Oct. 1. Good day. It would be ideal that this magnificent newspaper make the Spanish version of such good articles as this one. Thank you!
Source: washingtonpost - 🏆 95. / 72 Read more »

Eli Lilly to Pull Cancer Drug From Market After Failed StudyEli Lilly plans to withdraw its cancer drug Lartruvo from the market after a study showed that it failed to prolong overall survival in a clinical trial.
Source: WSJ - 🏆 98. / 63 Read more »